Results 201 to 210 of about 20,192 (256)
Some of the next articles are maybe not open access.
Archives of Ophthalmology, 1981
To the Editor. —There is increasing evidence of systemic side effects secondary to topical ocular administration of timolol maleate for the treatment of glaucoma. 1,2 These systemic side effects are essentially the same as those seen from systemically administered β-blockers.
E. Michael Van Buskirk +1 more
openaire +3 more sources
To the Editor. —There is increasing evidence of systemic side effects secondary to topical ocular administration of timolol maleate for the treatment of glaucoma. 1,2 These systemic side effects are essentially the same as those seen from systemically administered β-blockers.
E. Michael Van Buskirk +1 more
openaire +3 more sources
Vestnik oftal'mologii, 2019
In recent years, β-adrenergic blockers have become the first choice drugs for glaucoma treatment. Timolol holds the main position among them, being a part of most combined antiglaucoma preparations. The use of timolol maleate in clinical practice may be accompanied by severe side effects affecting different organs and systems.
K. I. Turkina +3 more
openaire +2 more sources
In recent years, β-adrenergic blockers have become the first choice drugs for glaucoma treatment. Timolol holds the main position among them, being a part of most combined antiglaucoma preparations. The use of timolol maleate in clinical practice may be accompanied by severe side effects affecting different organs and systems.
K. I. Turkina +3 more
openaire +2 more sources
Drugs & Aging, 2006
Travoprost 0.004%/timolol 0.5% fixed combination (travoprost/timolol) is a once-daily eyedrops solution comprising the prostaglandin F(2alpha) analogue travoprost and the beta-adrenoceptor antagonist timolol. It is indicated for the treatment of patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta ...
Susan J Keam +2 more
openaire +3 more sources
Travoprost 0.004%/timolol 0.5% fixed combination (travoprost/timolol) is a once-daily eyedrops solution comprising the prostaglandin F(2alpha) analogue travoprost and the beta-adrenoceptor antagonist timolol. It is indicated for the treatment of patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta ...
Susan J Keam +2 more
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1979
To the Editor.— The Journalis to be congratulated for publication of the article on timolol maleate (241:2301, 1979). At the Wills Eye Hospital, we have had considerable experience in the investigational and clinical use of timolol. We believe a few comments should be added to Dr Kosman's review.
George L Spaeth, Richard P. Wilson
openaire +3 more sources
To the Editor.— The Journalis to be congratulated for publication of the article on timolol maleate (241:2301, 1979). At the Wills Eye Hospital, we have had considerable experience in the investigational and clinical use of timolol. We believe a few comments should be added to Dr Kosman's review.
George L Spaeth, Richard P. Wilson
openaire +3 more sources
Acta Ophthalmologica, 1986
Abstract The influence of timolol on the corneal epithelium and endothelium was studied in organ culture. The cell morphology was not influenced by drug concentrations ≦ 690 μg/ml. Cell death was observed at 6900 μg/ml. Endothelial cell proliferation after an experimental injury was slowed down at a drug concentration of 690 μg/ml.
Martin Davanger, Erling Grøvold Olsen
openaire +3 more sources
Abstract The influence of timolol on the corneal epithelium and endothelium was studied in organ culture. The cell morphology was not influenced by drug concentrations ≦ 690 μg/ml. Cell death was observed at 6900 μg/ml. Endothelial cell proliferation after an experimental injury was slowed down at a drug concentration of 690 μg/ml.
Martin Davanger, Erling Grøvold Olsen
openaire +3 more sources
Biomaterials Science, 2018
Glaucoma is a chronic disease, which is currently treated using frequent high dose applications of an eye drop solution; this method is tedious, and most of patients are non-compliant to it.
Ankita R. Desai +6 more
semanticscholar +1 more source
Glaucoma is a chronic disease, which is currently treated using frequent high dose applications of an eye drop solution; this method is tedious, and most of patients are non-compliant to it.
Ankita R. Desai +6 more
semanticscholar +1 more source
Archives of Ophthalmology, 1989
To the Editor. —In the July 1988 issue of theArchives, Lynch et al 1 reported on 18 patients with central nervous system (CNS) effects during timolol maleate therapy whose condition improved after switching to betaxolol hydrochloride therapy. Unfortunately, however, they did not report on the intraocular pressure.
Jelle de Vries +2 more
openaire +3 more sources
To the Editor. —In the July 1988 issue of theArchives, Lynch et al 1 reported on 18 patients with central nervous system (CNS) effects during timolol maleate therapy whose condition improved after switching to betaxolol hydrochloride therapy. Unfortunately, however, they did not report on the intraocular pressure.
Jelle de Vries +2 more
openaire +3 more sources
Timolol in Migraine Prophylaxis
Headache: The Journal of Head and Face Pain, 1979SYNOPSISThe literature on the use of beta‐blocking drugs in migraine suggests that not all such agents are effective. A double‐blind crossover study of timolol in migraine prophylaxis was undertaken with fourteen patients, in order to assess the value of this drug in particular, and also to elucidate further the reason for the varied response to ...
Briggs, R S, Millac, P A
openaire +4 more sources
Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas
Pediatric dermatology, 2019First‐line therapy for infantile hemangiomas (IH) is oral propranolol, a systemic beta‐blocker with the risk of rare but serious adverse effects. Topical timolol presents an attractive off‐label alternative with good tolerability, but sequential therapy ...
D. Mannschreck +4 more
semanticscholar +1 more source
Ophthalmology, 1981
This collaborative study involves 39 investigators and shows the effects of timolol maleate when used short-term on large numbers of patients (418). Intraocular pressure response is excellent. Statistical analyses of pressure response are done using random sampling.
Gordon Krip, Raymond P. LeBlanc
openaire +3 more sources
This collaborative study involves 39 investigators and shows the effects of timolol maleate when used short-term on large numbers of patients (418). Intraocular pressure response is excellent. Statistical analyses of pressure response are done using random sampling.
Gordon Krip, Raymond P. LeBlanc
openaire +3 more sources